Literature DB >> 17139363

Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.

Lisa Gallinaro1, Francesca Sartorello, Elena Pontara, Maria Grazia Cattini, Antonella Bertomoro, Lucia Bartoloni, Antonio Pagnan, Alessandra Casonato.   

Abstract

We describe the complex picture associated with a mutated splice junction in intron 13 of von Willebrand factor (VWF) gene. The proband, characterized by a marked decrease in plasma and platelet VWF and near normal multimer organization, was classified as recessive type 1 von Willebrand disease (VWD). Genetic analysis demonstrated that he was homozygous for the 1534-3C > A mutation in the consensus sequence of the acceptor splicing site of intron 13 of the VWF gene. Platelet mRNA analysis documented three VWF transcripts: a wild type generated by the correct recognition of the mutated splice site, a smaller transcript not containing exon 14, and a longer one that, in addition to exons 13 and 14, included a 62bp fragment corresponding to the end of intron 13. The small transcript derives from the skipping of exon 14, the long one from the activation of a cryptic splice site in intron 13; both show a premature stop codon in VWF propeptide, so the proband VWF derives entirely from the correct splice site recognition. Combined incomplete exon skipping and cryptic splice site activation are first recognized in VWD. Since the 1534-3C > A mutation does not abolish the normal processing of mRNA, it is unlikely to be found in type 3 VWD. This mutation therefore appears to be peculiar to type 1 VWD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139363

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Splice-Site Mutation of Exon 3 Deletion in the Gamma-Glutamyl Carboxylase Gene Causes Inactivation of the Enzyme.

Authors:  Da-Yun Jin; Cees Vermeer; Darrel W Stafford; Jian-Ke Tie
Journal:  J Invest Dermatol       Date:  2016-07-06       Impact factor: 8.551

2.  Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.

Authors:  Marco Campos; Wei Sun; Fuli Yu; Maja Barbalic; Weihong Tang; Lloyd E Chambless; Kenneth K Wu; Christie Ballantyne; Aaron R Folsom; Eric Boerwinkle; Jing-Fei Dong
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

3.  An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Authors:  Viviana Daidone; Lisa Gallinaro; Maria Grazia Cattini; Elena Pontara; Antonella Bertomoro; Antonio Pagnan; Alessandra Casonato
Journal:  Haematologica       Date:  2011-03-10       Impact factor: 9.941

4.  Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.

Authors:  Lindsey Hawke; Mackenzie L Bowman; Man-Chiu Poon; Mary-Frances Scully; Georges-Etienne Rivard; Paula D James
Journal:  Blood       Date:  2016-06-17       Impact factor: 22.113

5.  Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.

Authors:  Alessandra Casonato; Maria Grazia Cattini; Viviana Daidone; Elena Pontara; Antonella Bertomoro; Paolo Prandoni
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

6.  Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and mice.

Authors:  Abigail R Moye; Nicola Bedoni; Jessica G Cunningham; Urikhan Sanzhaeva; Eric S Tucker; Peter Mathers; Virginie G Peter; Mathieu Quinodoz; Liliana P Paris; Luísa Coutinho-Santos; Pedro Camacho; Madeleine G Purcell; Abbie C Winkelmann; James A Foster; Elena N Pugacheva; Carlo Rivolta; Visvanathan Ramamurthy
Journal:  PLoS Genet       Date:  2019-08-19       Impact factor: 5.917

7.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10

8.  Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA.

Authors:  Nina Borràs; Gerard Orriols; Javier Batlle; Almudena Pérez-Rodríguez; Teresa Fidalgo; Patricia Martinho; María Fernanda López-Fernández; Ángela Rodríguez-Trillo; Esther Lourés; Rafael Parra; Carme Altisent; Ana Rosa Cid; Santiago Bonanad; Noelia Cabrera; Andrés Moret; María Eva Mingot-Castellano; Nira Navarro; Rocío Pérez-Montes; Sally Marcellin; Ana Moreto; Sonia Herrero; Inmaculada Soto; Núria Fernández-Mosteirín; Víctor Jiménez-Yuste; Nieves Alonso; Aurora de Andrés-Jacob; Emilia Fontanes; Rosa Campos; María José Paloma; Nuria Bermejo; Ruben Berrueco; José Mateo; Karmele Arribalzaga; Pascual Marco; Ángeles Palomo; Nerea Castro Quismondo; Belén Iñigo; María Del Mar Nieto; Rosa Vidal; María Paz Martínez; Reyes Aguinaco; Jesús María Tenorio; María Ferreiro; Javier García-Frade; Ana María Rodríguez-Huerta; Jorge Cuesta; Ramón Rodríguez-González; Faustino García-Candel; Manuela Dobón; Carlos Aguilar; Francisco Vidal; Irene Corrales
Journal:  Haematologica       Date:  2018-10-25       Impact factor: 9.941

9.  A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.

Authors:  Hamideh Yadegari; Muhammad Ahmer Jamil; Natascha Marquardt; Johannes Oldenburg
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.